Pet Recombinant Vaccine Market, Global Outlook and Forecast 2022-2028
Vaccines prepared at the genetic level for pet vaccination are called pet recombinant vaccines.
This report contains market size and forecasts of Pet Recombinant Vaccine in global, including the following market information:
Global Pet Recombinant Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pet Recombinant Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Pet Recombinant Vaccine companies in 2021 (%)
The global Pet Recombinant Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Genetically Engineered Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pet Recombinant Vaccine include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska, Merck Animal Health, Merial (Sanofi) and Virbac and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pet Recombinant Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pet Recombinant Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pet Recombinant Vaccine Market Segment Percentages, by Type, 2021 (%)
Global Pet Recombinant Vaccine Market Segment Percentages, by Application, 2021 (%)
Global Pet Recombinant Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Pet Recombinant Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pet Recombinant Vaccine revenues share in global market, 2021 (%)
Key companies Pet Recombinant Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Pet Recombinant Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Pet Recombinant Vaccine in global, including the following market information:
Global Pet Recombinant Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pet Recombinant Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Pet Recombinant Vaccine companies in 2021 (%)
The global Pet Recombinant Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Genetically Engineered Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pet Recombinant Vaccine include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska, Merck Animal Health, Merial (Sanofi) and Virbac and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pet Recombinant Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pet Recombinant Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pet Recombinant Vaccine Market Segment Percentages, by Type, 2021 (%)
- Genetically Engineered Vaccines
- Genetically Recombinant Vaccines
- Transgenic Plant Vaccines
- DNA Vaccines
Global Pet Recombinant Vaccine Market Segment Percentages, by Application, 2021 (%)
- Dog
- Cat
- Dird
- Others
Global Pet Recombinant Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Pet Recombinant Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pet Recombinant Vaccine revenues share in global market, 2021 (%)
Key companies Pet Recombinant Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Pet Recombinant Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bayer Healthcare
- Vetoquinol S.A
- Boehringer Ingelheim
- Ceva
- Eli Lilly
- Heska
- Merck Animal Health
- Merial (Sanofi)
- Virbac
- Zoetis (Pfizer)
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Pet Recombinant Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pet Recombinant Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PET RECOMBINANT VACCINE OVERALL MARKET SIZE
2.1 Global Pet Recombinant Vaccine Market Size: 2021 VS 2028
2.2 Global Pet Recombinant Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Pet Recombinant Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Pet Recombinant Vaccine Players in Global Market
3.2 Top Global Pet Recombinant Vaccine Companies Ranked by Revenue
3.3 Global Pet Recombinant Vaccine Revenue by Companies
3.4 Global Pet Recombinant Vaccine Sales by Companies
3.5 Global Pet Recombinant Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Pet Recombinant Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Pet Recombinant Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pet Recombinant Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Pet Recombinant Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Pet Recombinant Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Pet Recombinant Vaccine Market Size Markets, 2021 & 2028
4.1.2 Genetically Engineered Vaccines
4.1.3 Genetically Recombinant Vaccines
4.1.4 Transgenic Plant Vaccines
4.1.5 DNA Vaccines
4.2 By Type - Global Pet Recombinant Vaccine Revenue & Forecasts
4.2.1 By Type - Global Pet Recombinant Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Pet Recombinant Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Pet Recombinant Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Pet Recombinant Vaccine Sales & Forecasts
4.3.1 By Type - Global Pet Recombinant Vaccine Sales, 2017-2022
4.3.2 By Type - Global Pet Recombinant Vaccine Sales, 2023-2028
4.3.3 By Type - Global Pet Recombinant Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Pet Recombinant Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Pet Recombinant Vaccine Market Size, 2021 & 2028
5.1.2 Dog
5.1.3 Cat
5.1.4 Dird
5.1.5 Others
5.2 By Application - Global Pet Recombinant Vaccine Revenue & Forecasts
5.2.1 By Application - Global Pet Recombinant Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Pet Recombinant Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Pet Recombinant Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Pet Recombinant Vaccine Sales & Forecasts
5.3.1 By Application - Global Pet Recombinant Vaccine Sales, 2017-2022
5.3.2 By Application - Global Pet Recombinant Vaccine Sales, 2023-2028
5.3.3 By Application - Global Pet Recombinant Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Pet Recombinant Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Pet Recombinant Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Pet Recombinant Vaccine Revenue & Forecasts
6.2.1 By Region - Global Pet Recombinant Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Pet Recombinant Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Pet Recombinant Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Pet Recombinant Vaccine Sales & Forecasts
6.3.1 By Region - Global Pet Recombinant Vaccine Sales, 2017-2022
6.3.2 By Region - Global Pet Recombinant Vaccine Sales, 2023-2028
6.3.3 By Region - Global Pet Recombinant Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Pet Recombinant Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Pet Recombinant Vaccine Sales, 2017-2028
6.4.3 US Pet Recombinant Vaccine Market Size, 2017-2028
6.4.4 Canada Pet Recombinant Vaccine Market Size, 2017-2028
6.4.5 Mexico Pet Recombinant Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Pet Recombinant Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Pet Recombinant Vaccine Sales, 2017-2028
6.5.3 Germany Pet Recombinant Vaccine Market Size, 2017-2028
6.5.4 France Pet Recombinant Vaccine Market Size, 2017-2028
6.5.5 U.K. Pet Recombinant Vaccine Market Size, 2017-2028
6.5.6 Italy Pet Recombinant Vaccine Market Size, 2017-2028
6.5.7 Russia Pet Recombinant Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Pet Recombinant Vaccine Market Size, 2017-2028
6.5.9 Benelux Pet Recombinant Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Pet Recombinant Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Pet Recombinant Vaccine Sales, 2017-2028
6.6.3 China Pet Recombinant Vaccine Market Size, 2017-2028
6.6.4 Japan Pet Recombinant Vaccine Market Size, 2017-2028
6.6.5 South Korea Pet Recombinant Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Pet Recombinant Vaccine Market Size, 2017-2028
6.6.7 India Pet Recombinant Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Pet Recombinant Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Pet Recombinant Vaccine Sales, 2017-2028
6.7.3 Brazil Pet Recombinant Vaccine Market Size, 2017-2028
6.7.4 Argentina Pet Recombinant Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pet Recombinant Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Pet Recombinant Vaccine Sales, 2017-2028
6.8.3 Turkey Pet Recombinant Vaccine Market Size, 2017-2028
6.8.4 Israel Pet Recombinant Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Pet Recombinant Vaccine Market Size, 2017-2028
6.8.6 UAE Pet Recombinant Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Bayer Healthcare
7.1.1 Bayer Healthcare Corporate Summary
7.1.2 Bayer Healthcare Business Overview
7.1.3 Bayer Healthcare Pet Recombinant Vaccine Major Product Offerings
7.1.4 Bayer Healthcare Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Bayer Healthcare Key News
7.2 Vetoquinol S.A
7.2.1 Vetoquinol S.A Corporate Summary
7.2.2 Vetoquinol S.A Business Overview
7.2.3 Vetoquinol S.A Pet Recombinant Vaccine Major Product Offerings
7.2.4 Vetoquinol S.A Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Vetoquinol S.A Key News
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporate Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Pet Recombinant Vaccine Major Product Offerings
7.3.4 Boehringer Ingelheim Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Boehringer Ingelheim Key News
7.4 Ceva
7.4.1 Ceva Corporate Summary
7.4.2 Ceva Business Overview
7.4.3 Ceva Pet Recombinant Vaccine Major Product Offerings
7.4.4 Ceva Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Ceva Key News
7.5 Eli Lilly
7.5.1 Eli Lilly Corporate Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Pet Recombinant Vaccine Major Product Offerings
7.5.4 Eli Lilly Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Eli Lilly Key News
7.6 Heska
7.6.1 Heska Corporate Summary
7.6.2 Heska Business Overview
7.6.3 Heska Pet Recombinant Vaccine Major Product Offerings
7.6.4 Heska Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Heska Key News
7.7 Merck Animal Health
7.7.1 Merck Animal Health Corporate Summary
7.7.2 Merck Animal Health Business Overview
7.7.3 Merck Animal Health Pet Recombinant Vaccine Major Product Offerings
7.7.4 Merck Animal Health Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Merck Animal Health Key News
7.8 Merial (Sanofi)
7.8.1 Merial (Sanofi) Corporate Summary
7.8.2 Merial (Sanofi) Business Overview
7.8.3 Merial (Sanofi) Pet Recombinant Vaccine Major Product Offerings
7.8.4 Merial (Sanofi) Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Merial (Sanofi) Key News
7.9 Virbac
7.9.1 Virbac Corporate Summary
7.9.2 Virbac Business Overview
7.9.3 Virbac Pet Recombinant Vaccine Major Product Offerings
7.9.4 Virbac Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Virbac Key News
7.10 Zoetis (Pfizer)
7.10.1 Zoetis (Pfizer) Corporate Summary
7.10.2 Zoetis (Pfizer) Business Overview
7.10.3 Zoetis (Pfizer) Pet Recombinant Vaccine Major Product Offerings
7.10.4 Zoetis (Pfizer) Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Zoetis (Pfizer) Key News
8 GLOBAL PET RECOMBINANT VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Pet Recombinant Vaccine Production Capacity, 2017-2028
8.2 Pet Recombinant Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Pet Recombinant Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PET RECOMBINANT VACCINE SUPPLY CHAIN ANALYSIS
10.1 Pet Recombinant Vaccine Industry Value Chain
10.2 Pet Recombinant Vaccine Upstream Market
10.3 Pet Recombinant Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pet Recombinant Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Pet Recombinant Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pet Recombinant Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PET RECOMBINANT VACCINE OVERALL MARKET SIZE
2.1 Global Pet Recombinant Vaccine Market Size: 2021 VS 2028
2.2 Global Pet Recombinant Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Pet Recombinant Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Pet Recombinant Vaccine Players in Global Market
3.2 Top Global Pet Recombinant Vaccine Companies Ranked by Revenue
3.3 Global Pet Recombinant Vaccine Revenue by Companies
3.4 Global Pet Recombinant Vaccine Sales by Companies
3.5 Global Pet Recombinant Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Pet Recombinant Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Pet Recombinant Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pet Recombinant Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Pet Recombinant Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Pet Recombinant Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Pet Recombinant Vaccine Market Size Markets, 2021 & 2028
4.1.2 Genetically Engineered Vaccines
4.1.3 Genetically Recombinant Vaccines
4.1.4 Transgenic Plant Vaccines
4.1.5 DNA Vaccines
4.2 By Type - Global Pet Recombinant Vaccine Revenue & Forecasts
4.2.1 By Type - Global Pet Recombinant Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Pet Recombinant Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Pet Recombinant Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Pet Recombinant Vaccine Sales & Forecasts
4.3.1 By Type - Global Pet Recombinant Vaccine Sales, 2017-2022
4.3.2 By Type - Global Pet Recombinant Vaccine Sales, 2023-2028
4.3.3 By Type - Global Pet Recombinant Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Pet Recombinant Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Pet Recombinant Vaccine Market Size, 2021 & 2028
5.1.2 Dog
5.1.3 Cat
5.1.4 Dird
5.1.5 Others
5.2 By Application - Global Pet Recombinant Vaccine Revenue & Forecasts
5.2.1 By Application - Global Pet Recombinant Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Pet Recombinant Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Pet Recombinant Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Pet Recombinant Vaccine Sales & Forecasts
5.3.1 By Application - Global Pet Recombinant Vaccine Sales, 2017-2022
5.3.2 By Application - Global Pet Recombinant Vaccine Sales, 2023-2028
5.3.3 By Application - Global Pet Recombinant Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Pet Recombinant Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Pet Recombinant Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Pet Recombinant Vaccine Revenue & Forecasts
6.2.1 By Region - Global Pet Recombinant Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Pet Recombinant Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Pet Recombinant Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Pet Recombinant Vaccine Sales & Forecasts
6.3.1 By Region - Global Pet Recombinant Vaccine Sales, 2017-2022
6.3.2 By Region - Global Pet Recombinant Vaccine Sales, 2023-2028
6.3.3 By Region - Global Pet Recombinant Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Pet Recombinant Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Pet Recombinant Vaccine Sales, 2017-2028
6.4.3 US Pet Recombinant Vaccine Market Size, 2017-2028
6.4.4 Canada Pet Recombinant Vaccine Market Size, 2017-2028
6.4.5 Mexico Pet Recombinant Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Pet Recombinant Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Pet Recombinant Vaccine Sales, 2017-2028
6.5.3 Germany Pet Recombinant Vaccine Market Size, 2017-2028
6.5.4 France Pet Recombinant Vaccine Market Size, 2017-2028
6.5.5 U.K. Pet Recombinant Vaccine Market Size, 2017-2028
6.5.6 Italy Pet Recombinant Vaccine Market Size, 2017-2028
6.5.7 Russia Pet Recombinant Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Pet Recombinant Vaccine Market Size, 2017-2028
6.5.9 Benelux Pet Recombinant Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Pet Recombinant Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Pet Recombinant Vaccine Sales, 2017-2028
6.6.3 China Pet Recombinant Vaccine Market Size, 2017-2028
6.6.4 Japan Pet Recombinant Vaccine Market Size, 2017-2028
6.6.5 South Korea Pet Recombinant Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Pet Recombinant Vaccine Market Size, 2017-2028
6.6.7 India Pet Recombinant Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Pet Recombinant Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Pet Recombinant Vaccine Sales, 2017-2028
6.7.3 Brazil Pet Recombinant Vaccine Market Size, 2017-2028
6.7.4 Argentina Pet Recombinant Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pet Recombinant Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Pet Recombinant Vaccine Sales, 2017-2028
6.8.3 Turkey Pet Recombinant Vaccine Market Size, 2017-2028
6.8.4 Israel Pet Recombinant Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Pet Recombinant Vaccine Market Size, 2017-2028
6.8.6 UAE Pet Recombinant Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Bayer Healthcare
7.1.1 Bayer Healthcare Corporate Summary
7.1.2 Bayer Healthcare Business Overview
7.1.3 Bayer Healthcare Pet Recombinant Vaccine Major Product Offerings
7.1.4 Bayer Healthcare Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Bayer Healthcare Key News
7.2 Vetoquinol S.A
7.2.1 Vetoquinol S.A Corporate Summary
7.2.2 Vetoquinol S.A Business Overview
7.2.3 Vetoquinol S.A Pet Recombinant Vaccine Major Product Offerings
7.2.4 Vetoquinol S.A Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Vetoquinol S.A Key News
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporate Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Pet Recombinant Vaccine Major Product Offerings
7.3.4 Boehringer Ingelheim Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Boehringer Ingelheim Key News
7.4 Ceva
7.4.1 Ceva Corporate Summary
7.4.2 Ceva Business Overview
7.4.3 Ceva Pet Recombinant Vaccine Major Product Offerings
7.4.4 Ceva Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Ceva Key News
7.5 Eli Lilly
7.5.1 Eli Lilly Corporate Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Pet Recombinant Vaccine Major Product Offerings
7.5.4 Eli Lilly Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Eli Lilly Key News
7.6 Heska
7.6.1 Heska Corporate Summary
7.6.2 Heska Business Overview
7.6.3 Heska Pet Recombinant Vaccine Major Product Offerings
7.6.4 Heska Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Heska Key News
7.7 Merck Animal Health
7.7.1 Merck Animal Health Corporate Summary
7.7.2 Merck Animal Health Business Overview
7.7.3 Merck Animal Health Pet Recombinant Vaccine Major Product Offerings
7.7.4 Merck Animal Health Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Merck Animal Health Key News
7.8 Merial (Sanofi)
7.8.1 Merial (Sanofi) Corporate Summary
7.8.2 Merial (Sanofi) Business Overview
7.8.3 Merial (Sanofi) Pet Recombinant Vaccine Major Product Offerings
7.8.4 Merial (Sanofi) Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Merial (Sanofi) Key News
7.9 Virbac
7.9.1 Virbac Corporate Summary
7.9.2 Virbac Business Overview
7.9.3 Virbac Pet Recombinant Vaccine Major Product Offerings
7.9.4 Virbac Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Virbac Key News
7.10 Zoetis (Pfizer)
7.10.1 Zoetis (Pfizer) Corporate Summary
7.10.2 Zoetis (Pfizer) Business Overview
7.10.3 Zoetis (Pfizer) Pet Recombinant Vaccine Major Product Offerings
7.10.4 Zoetis (Pfizer) Pet Recombinant Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Zoetis (Pfizer) Key News
8 GLOBAL PET RECOMBINANT VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Pet Recombinant Vaccine Production Capacity, 2017-2028
8.2 Pet Recombinant Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Pet Recombinant Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PET RECOMBINANT VACCINE SUPPLY CHAIN ANALYSIS
10.1 Pet Recombinant Vaccine Industry Value Chain
10.2 Pet Recombinant Vaccine Upstream Market
10.3 Pet Recombinant Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pet Recombinant Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Pet Recombinant Vaccine in Global Market
Table 2. Top Pet Recombinant Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Pet Recombinant Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Pet Recombinant Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Pet Recombinant Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Pet Recombinant Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Pet Recombinant Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Pet Recombinant Vaccine Product Type
Table 9. List of Global Tier 1 Pet Recombinant Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pet Recombinant Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pet Recombinant Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Pet Recombinant Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Pet Recombinant Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Pet Recombinant Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Pet Recombinant Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Pet Recombinant Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Pet Recombinant Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Pet Recombinant Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Pet Recombinant Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Pet Recombinant Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Pet Recombinant Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Pet Recombinant Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Pet Recombinant Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Pet Recombinant Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Pet Recombinant Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Pet Recombinant Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Pet Recombinant Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Pet Recombinant Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Pet Recombinant Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Pet Recombinant Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Pet Recombinant Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Pet Recombinant Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Pet Recombinant Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Pet Recombinant Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Pet Recombinant Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Pet Recombinant Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Pet Recombinant Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Pet Recombinant Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Pet Recombinant Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Pet Recombinant Vaccine Sales, (K Units), 2023-2028
Table 46. Bayer Healthcare Corporate Summary
Table 47. Bayer Healthcare Pet Recombinant Vaccine Product Offerings
Table 48. Bayer Healthcare Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Vetoquinol S.A Corporate Summary
Table 50. Vetoquinol S.A Pet Recombinant Vaccine Product Offerings
Table 51. Vetoquinol S.A Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Boehringer Ingelheim Corporate Summary
Table 53. Boehringer Ingelheim Pet Recombinant Vaccine Product Offerings
Table 54. Boehringer Ingelheim Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Ceva Corporate Summary
Table 56. Ceva Pet Recombinant Vaccine Product Offerings
Table 57. Ceva Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Eli Lilly Corporate Summary
Table 59. Eli Lilly Pet Recombinant Vaccine Product Offerings
Table 60. Eli Lilly Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Heska Corporate Summary
Table 62. Heska Pet Recombinant Vaccine Product Offerings
Table 63. Heska Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Merck Animal Health Corporate Summary
Table 65. Merck Animal Health Pet Recombinant Vaccine Product Offerings
Table 66. Merck Animal Health Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Merial (Sanofi) Corporate Summary
Table 68. Merial (Sanofi) Pet Recombinant Vaccine Product Offerings
Table 69. Merial (Sanofi) Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Virbac Corporate Summary
Table 71. Virbac Pet Recombinant Vaccine Product Offerings
Table 72. Virbac Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Zoetis (Pfizer) Corporate Summary
Table 74. Zoetis (Pfizer) Pet Recombinant Vaccine Product Offerings
Table 75. Zoetis (Pfizer) Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Pet Recombinant Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Pet Recombinant Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Pet Recombinant Vaccine Production by Region, 2017-2022 (K Units)
Table 79. Global Pet Recombinant Vaccine Production by Region, 2023-2028 (K Units)
Table 80. Pet Recombinant Vaccine Market Opportunities & Trends in Global Market
Table 81. Pet Recombinant Vaccine Market Drivers in Global Market
Table 82. Pet Recombinant Vaccine Market Restraints in Global Market
Table 83. Pet Recombinant Vaccine Raw Materials
Table 84. Pet Recombinant Vaccine Raw Materials Suppliers in Global Market
Table 85. Typical Pet Recombinant Vaccine Downstream
Table 86. Pet Recombinant Vaccine Downstream Clients in Global Market
Table 87. Pet Recombinant Vaccine Distributors and Sales Agents in Global Market
Table 1. Key Players of Pet Recombinant Vaccine in Global Market
Table 2. Top Pet Recombinant Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Pet Recombinant Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Pet Recombinant Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Pet Recombinant Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Pet Recombinant Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Pet Recombinant Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Pet Recombinant Vaccine Product Type
Table 9. List of Global Tier 1 Pet Recombinant Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pet Recombinant Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pet Recombinant Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Pet Recombinant Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Pet Recombinant Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Pet Recombinant Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Pet Recombinant Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Pet Recombinant Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Pet Recombinant Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Pet Recombinant Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Pet Recombinant Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Pet Recombinant Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Pet Recombinant Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Pet Recombinant Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Pet Recombinant Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Pet Recombinant Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Pet Recombinant Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Pet Recombinant Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Pet Recombinant Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Pet Recombinant Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Pet Recombinant Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Pet Recombinant Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Pet Recombinant Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Pet Recombinant Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Pet Recombinant Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Pet Recombinant Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Pet Recombinant Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Pet Recombinant Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Pet Recombinant Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Pet Recombinant Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Pet Recombinant Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Pet Recombinant Vaccine Sales, (K Units), 2023-2028
Table 46. Bayer Healthcare Corporate Summary
Table 47. Bayer Healthcare Pet Recombinant Vaccine Product Offerings
Table 48. Bayer Healthcare Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Vetoquinol S.A Corporate Summary
Table 50. Vetoquinol S.A Pet Recombinant Vaccine Product Offerings
Table 51. Vetoquinol S.A Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Boehringer Ingelheim Corporate Summary
Table 53. Boehringer Ingelheim Pet Recombinant Vaccine Product Offerings
Table 54. Boehringer Ingelheim Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Ceva Corporate Summary
Table 56. Ceva Pet Recombinant Vaccine Product Offerings
Table 57. Ceva Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Eli Lilly Corporate Summary
Table 59. Eli Lilly Pet Recombinant Vaccine Product Offerings
Table 60. Eli Lilly Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Heska Corporate Summary
Table 62. Heska Pet Recombinant Vaccine Product Offerings
Table 63. Heska Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Merck Animal Health Corporate Summary
Table 65. Merck Animal Health Pet Recombinant Vaccine Product Offerings
Table 66. Merck Animal Health Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Merial (Sanofi) Corporate Summary
Table 68. Merial (Sanofi) Pet Recombinant Vaccine Product Offerings
Table 69. Merial (Sanofi) Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Virbac Corporate Summary
Table 71. Virbac Pet Recombinant Vaccine Product Offerings
Table 72. Virbac Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Zoetis (Pfizer) Corporate Summary
Table 74. Zoetis (Pfizer) Pet Recombinant Vaccine Product Offerings
Table 75. Zoetis (Pfizer) Pet Recombinant Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Pet Recombinant Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Pet Recombinant Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Pet Recombinant Vaccine Production by Region, 2017-2022 (K Units)
Table 79. Global Pet Recombinant Vaccine Production by Region, 2023-2028 (K Units)
Table 80. Pet Recombinant Vaccine Market Opportunities & Trends in Global Market
Table 81. Pet Recombinant Vaccine Market Drivers in Global Market
Table 82. Pet Recombinant Vaccine Market Restraints in Global Market
Table 83. Pet Recombinant Vaccine Raw Materials
Table 84. Pet Recombinant Vaccine Raw Materials Suppliers in Global Market
Table 85. Typical Pet Recombinant Vaccine Downstream
Table 86. Pet Recombinant Vaccine Downstream Clients in Global Market
Table 87. Pet Recombinant Vaccine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Pet Recombinant Vaccine Segment by Type
Figure 2. Pet Recombinant Vaccine Segment by Application
Figure 3. Global Pet Recombinant Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pet Recombinant Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pet Recombinant Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Pet Recombinant Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pet Recombinant Vaccine Revenue in 2021
Figure 9. By Type - Global Pet Recombinant Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Pet Recombinant Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Pet Recombinant Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Pet Recombinant Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Pet Recombinant Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Pet Recombinant Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Pet Recombinant Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Pet Recombinant Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Pet Recombinant Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Pet Recombinant Vaccine Sales Market Share, 2017-2028
Figure 19. US Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Pet Recombinant Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Pet Recombinant Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Pet Recombinant Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Pet Recombinant Vaccine Sales Market Share, 2017-2028
Figure 33. China Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Pet Recombinant Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Pet Recombinant Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Pet Recombinant Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Pet Recombinant Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Pet Recombinant Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Pet Recombinant Vaccine by Region, 2021 VS 2028
Figure 50. Pet Recombinant Vaccine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Pet Recombinant Vaccine Segment by Type
Figure 2. Pet Recombinant Vaccine Segment by Application
Figure 3. Global Pet Recombinant Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pet Recombinant Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pet Recombinant Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Pet Recombinant Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pet Recombinant Vaccine Revenue in 2021
Figure 9. By Type - Global Pet Recombinant Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Pet Recombinant Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Pet Recombinant Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Pet Recombinant Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Pet Recombinant Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Pet Recombinant Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Pet Recombinant Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Pet Recombinant Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Pet Recombinant Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Pet Recombinant Vaccine Sales Market Share, 2017-2028
Figure 19. US Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Pet Recombinant Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Pet Recombinant Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Pet Recombinant Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Pet Recombinant Vaccine Sales Market Share, 2017-2028
Figure 33. China Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Pet Recombinant Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Pet Recombinant Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Pet Recombinant Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Pet Recombinant Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Pet Recombinant Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Pet Recombinant Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Pet Recombinant Vaccine by Region, 2021 VS 2028
Figure 50. Pet Recombinant Vaccine Industry Value Chain
Figure 51. Marketing Channels
